US 12,106,125 B2
Development environment for generation of automated control pathways
John Covert, Kennett Square, PA (US); David Spangler, Hilton Head, SC (US); and Scott Betzel, Caledonia, IL (US)
Assigned to Evernorth Strategic Development, Inc., St. Louis, MO (US)
Filed by Evernorth Strategic Development, Inc., St. Louis, MO (US)
Filed on Oct. 7, 2021, as Appl. No. 17/496,273.
Prior Publication US 2023/0112311 A1, Apr. 13, 2023
Int. Cl. G06F 9/451 (2018.01); G06F 3/0482 (2013.01); G06F 3/0484 (2022.01); G06F 8/34 (2018.01); G16H 20/10 (2018.01); G16H 40/20 (2018.01); G16H 70/40 (2018.01); G16H 70/60 (2018.01)
CPC G06F 9/451 (2018.02) [G06F 3/0482 (2013.01); G06F 3/0484 (2013.01); G06F 8/34 (2013.01); G16H 20/10 (2018.01); G16H 40/20 (2018.01); G16H 70/40 (2018.01); G16H 70/60 (2018.01)] 16 Claims
OG exemplary drawing
 
1. A computerized method of generating an automated control pathway for a user interface, the method comprising:
displaying a graphical development environment for generation of the automated control pathway for a prescription drug authorization request, wherein the graphical development environment includes a palette area and multiple graphical programming elements, and wherein the multiple graphical programming elements include at least a question programming element and a determination programming element;
receiving a selection of the question programming element;
displaying the selected question programming element at a location in the palette area specified via user input;
receiving, via user input, at least one answer field specified for the selected question programming element;
displaying at least two pathway branches in the palette area, wherein the at least two pathway branches are associated with the selected question programming element, and the at least one answer field is assigned to one of the at least two pathway branches according to user input;
receiving a selection of the determination programming element;
associating, via user input, the selected determination programming element with the one of the at least two pathway branches;
assigning a status value to the selected determination programming element according to user input, wherein the status value includes a drug request approval indication or a drug request denial indication;
saving the automated control pathway in a production database, wherein the automated control pathway includes the selected question programming element, the selected determination programming element, and the assigned status value for the selected determination programming element;
running the automated control pathway to display a question associated with the selected question programming element on the user interface;
receiving, via the user interface, an answer to the displayed question;
determining the one of the at least two pathway branches associated with the received answer;
automatically transmitting an approval status or a denial status according to the status value assigned to the selected determination programming element associated with the determined one of the at least two pathway branches;
receiving, via the user interface, at least one clinical response indicative of a patient condition;
identifying, via the automated control pathway, at least one drug regimen associated with treatment of the patient condition;
displaying the identified at least one drug regimen via the user interface for selection by a user;
receiving a selection of the at least one drug regimen via the user interface; and
in response to a determination that the selected drug regimen is a national comprehensive cancer network (NCCN) recommended drug regimen, automatically transmitting an approval of an authorization request for the selected drug regimen.